IP Library › Granted Patent US 10,844,114
Granted Patent B2
US 10,844,114 · App. 16/400,818 · Granted Nov 24, 2020

Anti-

Inventors: Antonio DiGiandomenico (Gaithersburg, MD); Paul G. Warrener (Gaithersburg, MD); Charles K. Stover (Gaithersburg, MD); Bret Sellman (Gaithersburg, MD); Sandrine Guillard (Cambridge, GB); Ralph Minter (Cambridge, GB); Steven Rust (Cambridge, GB); Mladen Tomich (New York, NY)
Assignee: MedImmune Limited
C07K16/1214A61K47/6811A61K47/6835A61K38/00A61K2039/505C07K2317/21C07K2317/622C07K2317/64C07K2317/71C07K2317/73C07K2317/76C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,844,114
App. No.
16/400,818
Granted
Nov 24, 2020
Kind
B2
Abstract

This disclosure relates to an anti- Pseudomonas Psl binding molecule and uses thereof, in particular in prevention and treatment of Pseudomonas infection. Furthermore, the disclosure provides compositions and methods for preventing and treating Pseudomonas infection.

Claims (21)

1. An isolated polynucleotide comprising a nucleic acid encoding an antibody or antigen-binding fragment thereof, wherein the antibody or antigen-binding fragment comprises a heavy chain variable region (VH), wherein the VH comprises a VH complementarity determining region-1 (VHCDR1), VDCDR2, and VHCDR3 of amino acid sequences SEQ ID NO:47, 48, and 75, respectively, and the antibody or antigen-binding fragment comprises a light chain variable region (VL), wherein the VL comprises a VLCDR1, CDR2, and CDR3 of amino acids 50, 51, and 52, respectively.

2. A host cell comprising the polynucleotide of claim 1 .

3. The polynucleotide of claim 1 , wherein the antibody or fragment thereof comprises the VH and VL of SEQ ID NO:74 and SEQ ID NO:12, respectively.

4. A vector comprising the polynucleotide of claim 3 .

5. A host cell comprising the polynucleotide of claim 3 .

6. The polynucleotide of claim 3 , wherein the antibody or antigen-binding fragment thereof is a scFv.

7. A vector comprising the polynucleotide of claim 6 .

8. A host cell comprising the polynucleotide of claim 6 .

9. The polynucleotide of claim 1 wherein the antibody or fragment thereof is a monoclonal antibody, a humanized antibody, a chimeric antibody, a human antibody, an Fab fragment, an Fab′ fragment, an F(ab)2 fragment or a single chain Fv (scFv).

10. The polynucleotide of claim 9 , wherein the antibody or antigen-binding fragment thereof is a scFv.

11. A vector comprising the polynucleotide of claim 10 .

12. A host cell comprising the polynucleotide of claim 10 .

13. A vector comprising the polynucleotide of claim 1 .

14. The polynucleotide of claim 1 , wherein the antibody or antigen-binding fragment thereof comprises a VH of SEQ ID NO:74.

15. A vector comprising the polynucleotide of claim 14 .

16. The polynucleotide of claim 1 , wherein the antibody or antigen-binding fragment thereof comprises a VH of SEQ ID NO:12.

17. A vector comprising the polynucleotide of claim 16 .

18. An isolated polynucleotide comprising a nucleic acid encoding an antibody or antigen-binding fragment thereof that competitively inhibits Pseudomonas Psl binding by an antibody or antigen-binding fragment thereof comprising the heavy chain variable region (VH) and light chain variable region (VL) region of SEQ ID NO:74 and SEQ ID NO:12, respectively.

19. A vector comprising the polynucleotide of claim 18 .

20. A host cell comprising the polynucleotide of claim 18 .

21. A host cell comprising a polynucleotide encoding a VH comprising SEQ ID NO:74 and a polynucleotide encoding a VL comprising SEQ ID NO:12.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2019
From: GUILLARD, SANDRINE; MINTER, RALPH; RUST, STEVEN
To: MEDIMMUNE LIMITED
Reel/Frame 050162/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2019
From: DIGIANDOMENICO, ANTONIO; WARRENER, PAUL G.; STOVER, CHARLES K.; SELLMAN, BRET; TOMICH, MLADEN
To: MEDIMMUNE, LLC
Reel/Frame 050162/0961 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2019
From: MEDIMMUNE, LLC
To: MEDIMMUNE LIMITED
Reel/Frame 050163/0821 →
Continuity (6)
Division 15192072 · Jun 24, 2016
Division 14125073
Provisional Application 61613317 · Mar 20, 2012
Provisional Application 61530461 · Sep 2, 2011
Provisional Application 61495460 · Jun 10, 2011
Related Publication 20190322726A1 · Oct 24, 2019
Cited By (1)
US 12,428,473